Companies

MBX Biosciences, Inc. (MBX) SEC filings

CIK 0001776111 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Net income (USD)-61.9 M-32.6 M
Diluted EPS (USD/shares)-2.38-31.96

Latest filings

FiledFormDescriptionPeriod
2026-08-278-K8-K items 7.01,8.01,9.012026-08-27
2026-08-17144144
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-10SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-10SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,7.01,8.01,9.012026-08-06
2026-08-05442026-08-04
2026-08-04144144
2026-08-04144144
2026-08-04442026-08-03
2026-08-04442026-08-03
2026-07-29SCHEDULE 13GSCHEDULE 13G
2026-07-138-K8-K items 5.022026-07-09
2026-07-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-06-24SCHEDULE 13GSCHEDULE 13G
2026-06-128-K8-K items 7.01,8.01,9.012026-06-12
2026-06-10144144
2026-06-09144144
2026-06-05442026-06-04
2026-06-05442026-06-04
2026-06-05442026-06-04
2026-06-05442026-06-04
2026-06-05442026-06-04

Forms on file (last 1,000): 4 68, 8-K 27, 3 25, 144 17, SCHEDULE 13G/A 11, SCHEDULE 13D/A 8, CORRESP 8, 10-Q 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=MBX (0.002 USD), /gw/filings/filings?ticker=MBX&form=8-K, /gw/filings/facts?ticker=MBX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange